No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LBPH240719C25000
- 3.50
- +1.90+118.75%
15min DelayClose Jun 28 15:55 ET
3.50High1.20Low
1.20Open1.60Pre Close53 Volume1 Open Interest25.00Strike Price7.62KTurnover111.03%IV6.92%PremiumJul 19, 2024Expiry Date2.03Intrinsic Value100Multiplier20DDays to Expiry1.47Extrinsic Value100Contract SizeAmericanOptions Type0.6698Delta0.0509Gamma6.93Leverage Ratio-0.0656Theta0.0080Rho4.64Eff Leverage0.0232Vega
Intraday
- 5D
- Daily
News
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Express News | Longboard Pharmaceuticals Inc : Evercore ISI Raises Target Price to $57 From $44
Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target
Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.
Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $57 From $44, Maintains Outperform Rating
Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities